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Letter to the editorLinezolid-induced angioedema and urticaria in a patient
with renal failure
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3Dear editor,
Linezolid has demonstrated excellent activity against drug-
resistant Gram-positive bacteria infections, such as staphylo-
cocci, streptococci, and enterococci.1 However, linezolid is
associatedwithawide rangeof adverse effects suchasnausea,
diarrhea, vomiting, headache, and serotonin-like syndrome.2
Hematologic side effects, such as thrombocytopenia and ane-
mia, can also occur after linezolid treatment.2 Nevertheless,
angioedema and urticaria due to linezolid have not been
reported in previous literature. Here we report a case of a
patient who developed angioedema and urticaria after line-
zolid treatment.
A 48-years old Chinese man was admitted to our hospital
with complaints of fever for three days.Hehadbeendiagnosed
with chronic kidney disease (CKD) caused by hypertensive
nephropathy for ﬁve years, and began peritoneal dialysis three
years prior. He had no history of allergy. He was treated
with cefperazone-sulbactam before we got the culture results.
Three days later, ascite culture was positive for vancomycin-
sensitive Enterococcus faecium. Considering the safety and
effectiveness of antibiotic therapy, he was started on 600mg
linezolid intravenous (i.v.) twice daily.Meanwhile,we removed
the tube for peritoneal dialysis and changed it to hemodialy-
sis. 12h after linezolid therapy, he suffered serious swelling
of the bilateral eyelids and urticaria in the body. 12h later,
swelling aggravated, and blood test showed that eosinophilia
had increased to 34%. Linezolid was discontinued; cetirizine
and one dose of dexamethasone (5mg) were prescribed. We
changed the antibiotic to vancomycin for enterococci abdom-
inal infection. 12h later, the swelling was in remission and the
urticaria had disappeared. 24h after the withdrawal of line-
zolid treatment, the patient was totally relieved from swelling
of the eyelids and urticaria. Eosinophilia gradually declined to
normal levels after ten days.
We attributed the cause of angioedema and urticaria to
linezolid treatment because these side effects developed after
the treatment with linezolid, but resolved quickly after the
withdrawal of linezolid treatment. The other medications
were continued, including cefperazone-sulbactam. There was
4no evidence indicating suspicious food intake at the time the
rash developed. Based on the Naranjo adverse drug reaction
probability scale, the calculated score for a treatment-related
adverse event if angioedema and urticaria due to linezolidwas
8 out of amaximumof 13 points, indicating that it is a probable
cause.3
Acquired angioedema may be caused by drugs, such
as antibiotics, nonsteroidal anti-inﬂammatory drugs,
angiotensin-converting enzyme inhibitors, and radiocontrast
media.4,5 It can be an allergic (IgE-mediated) or non-allergic
hypersensitivity reaction, with similar clinical presentation.5
However, the mechanism of drug-induced angioedema and
urticaria remains unclear.
In summary, this is the ﬁrst report of the adverse effects
of angiodema and urticaria following linezolid treatment. We
report this case to increase clinicians’ awareness of additional
adverse effects of linezolid, especially for patients with renal
dysfunction, who have increased risk of developing these side
effects.
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